Similar to the mRNA findings, CD58 protein expression in untreated CLL cases remained statistically non-significant, and no significant differences were observed between the treated ALL groups and control cases, or between the ALL and CLL groups. This evidence concerns the gene CD58 and acute lymphoblastic leukemia.